Zontivity tablets, to reduce heart attacks and strokes, gets FDA approval

PRESS RELEASE   The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood More...